Previous study indicated that GABARAPL1 acts as a tumor suppressor protein, and showed that it inhibited cell proliferation, invasion and tumor growth in breast cancer and prostate cancer [28, 29, 30]. Here, GABARAPL1 is linked to prostate carcinoma.